Autor

Dr. Stefanie Greifeneder

Partnerin

Read More
Autor

Dr. Stefanie Greifeneder

Partnerin

Read More

30. Januar 2024 | 31:57 mins.

Webinar Series

Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1

Early stage IP strategy pays off – Our experts Dr. Anja Lunze, LL.M. & Tobias Baus explained the pros and cons of IP protection, how to build a custom IP strategy with a matching IP portfolio, and why early patent protection is essential for biotech & pharma start-ups.

Life science technologies will require a substantial amount of (external) financing to be successful. Our leading VC experts will help you navigate the funding process and avoid unnecessary pitfalls in negotiations with investors.

 

Download our presentation: Early Stage IP Protection

Coffee Break Life Sciences Start-ups

Sign up for our upcoming events.

To overview page
To overview page
Call To Action Arrow Image

Would you like to receive future invitations to our webinar series?

Then sign up for our mailing list.
Then sign up for our mailing list.
Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Handels- & Vertriebsrecht

Medical devices & the EU draft regulation on AI – new challenges for my business?

27. November 2023
In-depth analysis

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

Das Pharma-Paket der Europäischen Kommission: Kernziele und geplante Änderungen

25. Mai 2023
In-depth analysis

von Dr. Manja Epping und Dr. Stefanie Greifeneder

Klicken Sie hier für Details

Events

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.